Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Wire Cambodia.
Press releases published on April 2, 2025
Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
GlobeNewswire
·
April 2, 2025
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, …
Moringa: Learn Why These Moringa Powder Supplements Are Transforming Energy, Immunity, and Overall Health
GlobeNewswire
·
April 2, 2025
LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) -- Moringa Oleifera, often called the “Miracle Tree,” is rapidly gaining recognition in the U.S. as a superfood for its remarkable health benefits. From boosting daily energy levels to fortifying immune support, …
Cartesian Therapeutics Announces New Employment Inducement Grants
GlobeNewswire
·
April 2, 2025
FREDERICK, Md., April 02, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapies for the treatment of autoimmune diseases, today announced the granting of …
Building on Past Success, Incident IQ Names Ryan Zeek as Chief Financial Officer
GlobeNewswire
·
April 2, 2025
ATLANTA, April 02, 2025 (GLOBE NEWSWIRE) -- Incident IQ, the leading workflow management platform built specifically to streamline K-12 school districts, has announced the appointment of Ryan Zeek as Chief Financial Officer. Ryan steps into the role after …
SchoolAI Secures $25 Million to Help Teachers and Schools Reach Every Student
GlobeNewswire
·
April 2, 2025
LEHI, Utah, April 02, 2025 (GLOBE NEWSWIRE) -- SchoolAI, a leading AI platform for teaching and learning, today announced it has closed $25 million in Series A funding to tackle education’s fundamental challenge: helping teachers provide personalized …
Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment
GlobeNewswire
·
April 2, 2025
Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment First subjects dosed in double-blind, placebo-controlled trial assessing AT-7687’s safety, tolerability, …
Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum
GlobeNewswire
·
April 2, 2025
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of …
Tilray Shifts Cultivation of its Flagship Canadian Cannabis Brand and Strain, Good Supply Jean Guy, to Masson-Angers Facility in Québec
GlobeNewswire
·
April 2, 2025
MASSON-ANGERS, Quebec, April 02, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, and a leader …
Tilray Transfère la Culture de Sa Marque et de Sa Variété Canadienne Emblématique, Good Supply Jean Guy, à son Installation de Masson-Angers au Québec
GlobeNewswire
·
April 2, 2025
MASSON-ANGERS, Québec, 02 avr. 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (« Tilray ») (Nasdaq : TLRY ; TSX : TLRY), un leader mondial des biens de consommation, de l’industrie du cannabis, des boissons et du bien-être, ainsi qu'un acteur clé sur le …
Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors
GlobeNewswire
·
April 2, 2025
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced the appointment of Teresa Bitetti, …
Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting
GlobeNewswire
·
April 2, 2025
NEWTON, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer …
Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference
GlobeNewswire
·
April 2, 2025
CHATHAM, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that Seth Lederman M.D., …
Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases
GlobeNewswire
·
April 2, 2025
The undisclosed target is a central regulator of inflammation that is distinct from the previously disclosed STAT6 program Nurix DEL-AI drug discovery engine generated a drug discovery program to this previously undruggable target Nurix received a $15 …
Sophos Report: In 56% of Sophos IR and MDR Cases, Adversaries Logged In, Instead of Breaking In
GlobeNewswire
·
April 2, 2025
IR and MDR Cases Highlight Attackers Are Exfiltrating Data in Just Three Days Compromised Credentials Top Root Causes for Second Year OXFORD, U.K., April 02, 2025 (GLOBE NEWSWIRE) -- Sophos, a global leader of innovative security solutions for defeating …
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
GlobeNewswire
·
April 2, 2025
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein (a-syn) antibody levels on average over 20-fold …
YXT.com Rebrands as Radnova and Launches AI-Enabled Enterprise Productivity Solutions
GlobeNewswire
·
April 2, 2025
SUZHOU, China, April 02, 2025 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited (NASDAQ: YXT) (“YXT.com” or the “Company”), a provider of AI-enabled enterprise productivity solutions, today announced that it has successfully completed a strategic …
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
GlobeNewswire
·
April 2, 2025
STAFFORD, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy …
MISE À JOUR--Décideurs politiques mondiaux et géants de la technologie se réuniront à Abou Dhabi pour l’édition inaugurale du Sommet sur la Gouvernance des Technologies Émergentes
GlobeNewswire
·
April 2, 2025
ABU DHABI, Émirats arabes unis, 02 avr. 2025 (GLOBE NEWSWIRE) -- Le Conseil de recherche sur les technologies avancées (ATRC) des Émirats Arabes Unis a annoncé aujourd'hui le lancement de la première édition du Sommet sur la Gouvernance des Technologies …
Global NK Cell Therapy Clinical Trials FDA Approval Patent Market Size Report 2025
GlobeNewswire
·
April 2, 2025
Delhi, April 02, 2025 (GLOBE NEWSWIRE) -- Global Natural Killer (NK) Cell Therapy Clinical Trials, Proprietary Technologies, Collaborations and Market Opportunity Insight 2025 Report Highlights and Findings: Global …
VISTA Inhibitor Clinical Trials Market Size FDA Approval Patent Report 2025
GlobeNewswire
·
April 2, 2025
Delhi, April 02, 2025 (GLOBE NEWSWIRE) -- Global VISTA Inhibitor Clinical Trials, Drug Development Opportunities …